# Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

> **NCT01800968** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 300 (actual)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01800968
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01800968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01800968, "Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01800968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*